Stockreport

Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020 [Seeking Alpha]

Sol-Gel Technologies Ltd. - Ordinary Shares  (SLGL) 
Last sol-gel technologies ltd. - ordinary shares earnings: 11/13 07:05 am Check Earnings Report
PDF Summary Sol-Gel announced positive results from two studies using Twyneo to treat patients with acne vulgaris; NDA submission to the FDA for potential approval of the tr [Read more]